Header

UZH-Logo

Maintenance Infos

Publications for Arcaro, A

Navigate back| Up a level
Export as
Group by:
Number of items: 23.

2015

Salm, Fabiana; Dimitrova, Valeriya; von Bueren, André O; Ćwiek, Paulina; Rehrauer, Hubert; Djonov, Valentin; Anderle, Pascale; Arcaro, Alexandre (2015). The phosphoinositide 3-kinase p110α isoform regulates leukemia inhibitory factor receptor expression via c-Myc and miR-125b to promote cell proliferation in medulloblastoma. PLoS ONE, 10(4):e0123958.

2014

Höland, Katrin; Boller, Danielle; Hagel, Christian; Dolski, Silvia; Treszl, András; Pardo, Olivier E; Cwiek, Paulina; Salm, Fabiana; Leni, Zaira; Shepherd, Peter R; Styp-Rekowska, Beata; Djonov, Valentin; von Bueren, André O; Frei, Karl; Arcaro, Alexandre (2014). Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma. PLoS ONE, 9(4):e94132.

Fiaschetti, Giulio; Schroeder, Christina; Castelletti, Deborah; Arcaro, Alexandre; Westermann, Frank; Baumgartner, Martin; Shalaby, Tarek; Grotzer, Michael A (2014). NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. Acta Neuropathologica Communications, 2:39.

2013

Wojtalla, Anna; Fischer, Barbara; Kotelevets, Nataliya; Mauri, Francesco A; Sobek, Jens; Rehrauer, Hubert; Wotzkow, Carlos; Tschan, Mario P; Seckl, Michael J; Zangemeister-Wittke, Uwe; Arcaro, Alexandre (2013). Targeting the phosphoinositide 3-kinase p110-α isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer. Clinical Cancer Research, 19(1):96-105.

Liu, Yang; Käch, Andres; Ziegler, Urs; Ong, Albert C M; Wallace, Darren P; Arcaro, Alexandre; Serra, Andreas L (2013). The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease. PLoS ONE, 8(8):e73173.

2012

Wojtalla, Anna; Salm, Fabiana; Christiansen, Ditte G; Cremona, Tiziana; Cwiek, Paulina; Shalaby, Tarek; Gross, Nicole; Grotzer, Michael A; Arcaro, Alexandre (2012). Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma. PLoS ONE, 7(10):e47109.

Boller, Danielle; Doepfner, Kathrin T; De Laurentiis, Angela; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; Waterfield, Michael D; Arcaro, Alexandre (2012). Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer Research, 32(8):3015-3027.

2011

Guerreiro, A S; Fattet, S; Kulesza, D W; Atamer, A; Elsing, A N; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2011). A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Molecular Cancer Research, 9(7):925-935.

Fiaschetti, G; Castelletti, D; Zoller, S; Schramm, A; Schroeder, C; Nagaishi, M; Stearns, D; Mittelbronn, M; Eggert, A; Westermann, F; Ohgaki, H; Shalaby, T; Pruschy, M; Arcaro, A; Grotzer, M A (2011). Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene, 30(25):2823-2835.

Grotzer, M A; Shalaby, T; Arcaro, A (2011). Central nervous system atyypical teratoid/rhabdoid tumors: role of insulin-like factor I receptor. In: Hayat, M A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Brain Cancer. Heidelberg: Springer , 353-364.

Grunder, E; D'Ambrosio, R; Fiaschetti, G; Abela, L; Arcaro, A; Zuzak, T; Ohgaki, H; Lv, S Q; Shalaby, T; Grotzer, M (2011). MicroRNA-21 suppression impedes medulloblastoma cell migration. European Journal of Cancer, 47(16):2479-2490.

Fiaschetti, G; Grotzer, M A; Shalaby, T; Castelletti, D; Arcaro, A (2011). Quassinoids: From traditional drugs to new cancer therapeutics. Current Medicinal Chemistry, 18(3):316-328.

2010

Castelletti, D; Fiaschetti, G; Di Dato, V; Ziegler, U; Kumps, C; De Preter, K; Zollo, M; Speleman, F; Shalaby, T; De Martino, D; Berg, T; Eggert, A; Arcaro, A; Grotzer, M A (2010). The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors. Molecular Cancer Therapeutics, 9(12):3145-3157.

2009

Marinov, M; Ziogas, A; Pardo, O E; Tan, L T; Dhillon, T; Mauri, F A; Lane, H A; Lemoine, N R; Zangemeister-Wittke, U; Seckl, M J; Arcaro, A (2009). AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001. Clinical Cancer Research, 15(4):1277-1287.

Wu, M; Arcaro, A; Varga, Z; Vogetseder, A; Le Hir, M; Wüthrich, R P; Serra, A L (2009). Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease. American Journal of Physiology. Renal Physiology, 297(6):F1597-F1605.

von Bueren, A O; Shalaby, T; Oehler-Jänne, C; Arnold, L; Stearns, D; Eberhart, C G; Arcaro, A; Pruschy, M; Grotzer, M A (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer, 9:10.

Grotzer, M A; Castelletti, D; Fiaschetti, G; Shalaby, T; Arcaro, A (2009). Targeting Myc in pediatric malignancies of the central and peripheral nervous system. Current Cancer Drug Targets, 9(2):176-188.

2008

Fischer, B; Arcaro, A (2008). Current status of clinical trials for small cell lung cancer. Reviews on Recent Clinical Trials, 3(1):40-61.

Kemp, S J; Thorley, A J; Gorelik, J; Seckl, M J; O'Hare, M J; Arcaro, A; Korchev, Y; Goldstraw, P; Tetley, T D (2008). Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. American Journal of Respiratory Cell and Molecular Biology, 39(5):591-597.

Arcaro, A. Signaling by phosphoinositide 3-kinase isoforms downstream of receptor tyrosine kinases in human cancer. 2008, University of Zurich, Faculty of Medicine.

Guerreiro, A S; Fattet, S; Fischer, B; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2008). Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration. Clinical Cancer Research, 14(21):6761-6769.

Boller, D; Schramme, A; Doepfner, K T; Shalaby, T; von Bueren, A O; Eggert, A; Grotzer, M A; Arcaro, A (2008). Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. Clinical Cancer Research, 14(4):1172-1181.

2007

Wahl, P R; Le Hir, M; Vogetseder, A; Arcaro, A; Starke, A; Waeckerle-Men, Y; Serra, A L; Wuthrich, R P (2007). Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease. Nephrology, 12(4):357-363.

This list was generated on Sat Oct 21 00:40:28 2017 CEST.